Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 438

1.

The orphan nuclear receptor LRH-1/NR5a2 critically regulates T cell functions.

Seitz C, Huang J, Geiselhöringer AL, Galbani-Bianchi P, Michalek S, Phan TS, Reinhold C, Dietrich L, Schmidt C, Corazza N, Delgado E, Schnalzger T, Schoonjans K, Brunner T.

Sci Adv. 2019 Jul 17;5(7):eaav9732. doi: 10.1126/sciadv.aav9732. eCollection 2019 Jul.

PMID:
31328159
2.

Extra-Adrenal Glucocorticoid Synthesis in the Intestinal Mucosa: Between Immune Homeostasis and Immune Escape.

Ahmed A, Schmidt C, Brunner T.

Front Immunol. 2019 Jun 25;10:1438. doi: 10.3389/fimmu.2019.01438. eCollection 2019. Review.

3.

130th anniversary of Institut Pasteur: celebrating science.

Gougeon ML, Schwartz M, Brunner T, Ojcius DM.

Microbes Infect. 2019 Jun 25. pii: S1286-4579(19)30070-X. doi: 10.1016/j.micinf.2019.06.010. [Epub ahead of print] No abstract available.

PMID:
31247327
4.

A fast and simple fluorometric method to detect cell death in 3D intestinal organoids.

Bode KJ, Mueller S, Schweinlin M, Metzger M, Brunner T.

Biotechniques. 2019 Jul;67(1):23-28. doi: 10.2144/btn-2019-0023. Epub 2019 Jun 20.

5.

Consensus Report From the Miami Liver Proton Therapy Conference.

Chuong MD, Kaiser A, Khan F, Parikh P, Ben-Josef E, Crane C, Brunner T, Okumura T, Schreuder N, Bentzen SM, Gutierrez A, Mendez Romero A, Yoon SM, Sharma N, Kim TH, Kishi K, Moeslein F, Hoffe S, Schefter T, Hanish S, Scorsetti M, Apisarnthanarax S.

Front Oncol. 2019 May 31;9:457. doi: 10.3389/fonc.2019.00457. eCollection 2019.

6.

Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.

Fokas E, Allgäuer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Schmiegel W, Jacobasch L, Weitz J, Folprecht G, Schlenska-Lange A, Flentje M, Germer CT, Grützmann R, Schwarzbach M, Paolucci V, Bechstein WO, Friede T, Ghadimi M, Hofheinz RD, Rödel C; German Rectal Cancer Study Group.

J Clin Oncol. 2019 May 31:JCO1900308. doi: 10.1200/JCO.19.00308. [Epub ahead of print]

PMID:
31150315
7.

First report on extended distance between tumor lesion and adjacent organs at risk using interventionally applied balloon catheters: a simple procedure to optimize clinical target volume covering effective isodose in interstitial high-dose-rate brachytherapy of liver malignomas.

Hass P, Steffen IG, Powerski M, Mohnike K, Seidensticker M, Meyer F, Brunner T, Damm R, Willich C, Walke M, Karagiannis E, Omari J, Ricke J.

J Contemp Brachytherapy. 2019 Apr;11(2):152-161. doi: 10.5114/jcb.2019.84798. Epub 2019 Apr 29.

8.

Death Receptor Interactions With the Mitochondrial Cell Death Pathway During Immune Cell-, Drug- and Toxin-Induced Liver Damage.

Spinnenhirn V, Demgenski J, Brunner T.

Front Cell Dev Biol. 2019 Apr 24;7:72. doi: 10.3389/fcell.2019.00072. eCollection 2019. Review.

9.

130th anniversary of Institut Pasteur: celebrating science.

Gougeon ML, Schwartz M, Brunner T, Ojcius DM.

Genes Immun. 2019 May;20(5):342-343. doi: 10.1038/s41435-019-0070-3. Epub 2019 Apr 25. No abstract available.

PMID:
31019251
10.

Synthesis of Erythropoietins Site-Specifically Conjugated with Complex-Type N-Glycans.

Streichert K, Seitz C, Hoffmann E, Boos I, Jelkmann W, Brunner T, Unverzagt C, Rubini M.

Chembiochem. 2019 Apr 11. doi: 10.1002/cbic.201900023. [Epub ahead of print]

PMID:
30973186
11.

Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.

Brunner TB, Blanck O, Lewitzki V, Abbasi-Senger N, Momm F, Riesterer O, Duma MN, Wachter S, Baus W, Gerum S, Guckenberger M, Gkika E.

Radiother Oncol. 2019 Mar;132:42-47. doi: 10.1016/j.radonc.2018.11.015. Epub 2018 Dec 20.

PMID:
30825968
12.

The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases.

Klement RJ, Abbasi-Senger N, Adebahr S, Alheid H, Allgaeuer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Eble MJ, Ernst I, Gerum S, Habermehl D, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl H, Klass ND, Krempien R, Lewitzki V, Lohaus F, Ostheimer C, Papachristofilou A, Petersen C, Rieber J, Schneider T, Schrade E, Semrau R, Wachter S, Wittig A, Guckenberger M, Andratschke N.

BMC Cancer. 2019 Feb 26;19(1):173. doi: 10.1186/s12885-019-5362-5.

13.

Small renal carcinoma: the "when" and "how" of operation, active surveillance, and ablation.

Wendler JJ, Liehr BU, Damm R, Powerski M, Brunner T, Schostak M, Pech M.

Pol J Radiol. 2018 Dec 22;83:e561-e568. doi: 10.5114/pjr.2018.81282. eCollection 2018. Review.

14.

Breakfast eating patterns and drivers of a healthy breakfast composition.

Delley M, Brunner TA.

Appetite. 2019 Jun 1;137:90-98. doi: 10.1016/j.appet.2019.02.006. Epub 2019 Feb 21.

PMID:
30797836
15.

Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries.

Kroeze SGC, Fritz C, Basler L, Gkika E, Brunner TB, Grosu AL, Guckenberger M.

Strahlenther Onkol. 2019 Mar;195(3):199-206. doi: 10.1007/s00066-018-01422-5. Epub 2019 Feb 8.

PMID:
30737541
16.

Extra-adrenal glucocorticoid synthesis at epithelial barriers.

Phan TS, Merk VM, Brunner T.

Genes Immun. 2019 Jan 29. doi: 10.1038/s41435-019-0058-z. [Epub ahead of print]

PMID:
30692606
17.

The many faces of tumor necrosis factor signaling in the intestinal epithelium.

Delgado ME, Brunner T.

Genes Immun. 2019 Jan 28. doi: 10.1038/s41435-019-0057-0. [Epub ahead of print]

PMID:
30686825
18.

Intestinal glucocorticoid synthesis enzymes in pediatric inflammatory bowel disease patients.

Ahmed A, Schwaderer J, Hantusch A, Kolho KL, Brunner T.

Genes Immun. 2019 Jan 28. doi: 10.1038/s41435-019-0056-1. [Epub ahead of print]

PMID:
30686824
19.

Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factors.

Li J, Koerner J, Basler M, Brunner T, Kirk CJ, Groettrup M.

Kidney Int. 2019 Mar;95(3):611-623. doi: 10.1016/j.kint.2018.10.022. Epub 2019 Jan 23.

PMID:
30685098
20.

ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams : Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery.

Wilke L, Andratschke N, Blanck O, Brunner TB, Combs SE, Grosu AL, Moustakis C, Schmitt D, Baus WW, Guckenberger M.

Strahlenther Onkol. 2019 Mar;195(3):193-198. doi: 10.1007/s00066-018-1416-x. Epub 2019 Jan 16. Review.

PMID:
30649567
21.

Ecto-calreticulin is essential for an efficient immunogenic cell death stimulation in mouse melanoma : by Paola Giglio and colleagues, Genes and Immunity, October 4, 2018.

Brunner T.

Genes Immun. 2019 Jan 4. doi: 10.1038/s41435-018-0054-8. [Epub ahead of print] No abstract available.

PMID:
30607011
22.
23.

Prevention of neuronal apoptosis by astrocytes through thiol-mediated stress response modulation and accelerated recovery from proteotoxic stress.

Gutbier S, Spreng AS, Delp J, Schildknecht S, Karreman C, Suciu I, Brunner T, Groettrup M, Leist M.

Cell Death Differ. 2018 Dec;25(12):2101-2117. doi: 10.1038/s41418-018-0229-x. Epub 2018 Nov 2.

24.

Repeated SBRT for in- and out-of-field recurrences in the liver.

Gkika E, Strouthos I, Kirste S, Adebahr S, Schultheiss M, Bettinger D, Fritsch R, Brass V, Maruschke L, Neeff HP, Lang SA, Nestle U, Grosu AL, Brunner TB.

Strahlenther Onkol. 2019 Mar;195(3):246-253. doi: 10.1007/s00066-018-1385-0. Epub 2018 Oct 23.

PMID:
30353350
25.

TNFα sensitizes hepatocytes to FasL-induced apoptosis by NFκB-mediated Fas upregulation.

Faletti L, Peintner L, Neumann S, Sandler S, Grabinger T, Mac Nelly S, Merfort I, Huang CH, Tschaharganeh D, Kang TW, Heinzmann F, D'Artista L, Maurer U, Brunner T, Lowe S, Zender L, Borner C.

Cell Death Dis. 2018 Sep 5;9(9):909. doi: 10.1038/s41419-018-0935-9.

26.

Local synthesis of immunosuppressive glucocorticoids in the intestinal epithelium regulates anti-viral immune responses.

Huang J, Jia R, Brunner T.

Cell Immunol. 2018 Dec;334:1-10. doi: 10.1016/j.cellimm.2018.08.009. Epub 2018 Aug 18.

PMID:
30144940
27.

Message from the new Editors-in-Chief.

Brunner T, Gougeon ML.

Genes Immun. 2019 Apr;20(4):338-339. doi: 10.1038/s41435-018-0043-y. Epub 2018 Aug 17. No abstract available.

PMID:
30115974
28.

Effects of cold atmospheric plasma (CAP) on bacteria and mucosa of the upper aerodigestive tract.

Becker S, Zimmermann JL, Baumeister P, Brunner TF, Shimizu T, Li YF, Morfill GE, Harréus U, Welz C.

Auris Nasus Larynx. 2019 Apr;46(2):294-301. doi: 10.1016/j.anl.2018.07.008. Epub 2018 Aug 8.

PMID:
30098846
29.

Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis.

Bettinger D, Gkika E, Schultheiss M, Glaser N, Lange S, Maruschke L, Buettner N, Kirste S, Nestle U, Grosu AL, Thimme R, Brunner TB.

BMC Cancer. 2018 Aug 9;18(1):807. doi: 10.1186/s12885-018-4696-8.

30.

Feasibility of an iPad to Facilitate Communication in Postoperative Patients With Head and Neck Cancer.

Brunner TH, DiFortuna K, LeTang M, Murphy J, Stemplewicz K, Kovacs M, DeRosa AP, Gibson DS, Ginex PK.

J Perianesth Nurs. 2018 Aug;33(4):399-406. doi: 10.1016/j.jopan.2016.10.008. Epub 2017 Jun 7.

PMID:
30077281
31.

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies.

Schaub SK, Hartvigson PE, Lock MI, Høyer M, Brunner TB, Cardenes HR, Dawson LA, Kim EY, Mayr NA, Lo SS, Apisarnthanarax S.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818790217. doi: 10.1177/1533033818790217. Review.

32.

[Clinical target volume : Principles and limits].

Brunner TB, Walke M, Hass P.

Radiologe. 2018 Aug;58(8):730-735. doi: 10.1007/s00117-018-0414-4. Review. German.

PMID:
29947930
33.

Correspondence on Rajyaguru et al.

Boda-Heggemann J, Gkika E, Andratschke N, Blanck O, Guckenberger M, Lohr F, Brunner TB.

J Clin Oncol. 2018 Aug 20;36(24):2561-2562. doi: 10.1200/JCO.2018.78.1542. Epub 2018 Jun 26. No abstract available.

PMID:
29945524
34.

Signatures of Indistinguishability in Bosonic Many-Body Dynamics.

Brünner T, Dufour G, Rodríguez A, Buchleitner A.

Phys Rev Lett. 2018 May 25;120(21):210401. doi: 10.1103/PhysRevLett.120.210401.

PMID:
29883163
35.

[Small renal cell carcinoma-active surveillance and ablation].

Wendler JJ, Damm R, Liehr UB, Brunner T, Pech M, Schostak M.

Urologe A. 2018 Jun;57(6):731-743. doi: 10.1007/s00120-018-0677-4. German.

PMID:
29796702
36.

Counting on Death - Quantitative aspects of Bcl-2 family regulation.

Hantusch A, Rehm M, Brunner T.

FEBS J. 2018 Nov;285(22):4124-4138. doi: 10.1111/febs.14516. Epub 2018 May 31. Review.

PMID:
29791777
37.

Bax retrotranslocation potentiates Bcl-xL's antiapoptotic activity and is essential for switch-like transitions between MOMP competency and resistance.

Hantusch A, Das KK, García-Sáez AJ, Brunner T, Rehm M.

Cell Death Dis. 2018 Apr 1;9(4):430. doi: 10.1038/s41419-018-0464-6.

38.

Search for Neutrinoless Double-Beta Decay with the Upgraded EXO-200 Detector.

Albert JB, Anton G, Badhrees I, Barbeau PS, Bayerlein R, Beck D, Belov V, Breidenbach M, Brunner T, Cao GF, Cen WR, Chambers C, Cleveland B, Coon M, Craycraft A, Cree W, Daniels T, Danilov M, Daugherty SJ, Daughhetee J, Davis J, Delaquis S, Der Mesrobian-Kabakian A, DeVoe R, Didberidze T, Dilling J, Dolgolenko A, Dolinski MJ, Fairbank W, Farine J, Feyzbakhsh S, Fierlinger P, Fudenberg D, Gornea R, Graham K, Gratta G, Hall C, Hansen EV, Hoessl J, Hufschmidt P, Hughes M, Jamil A, Jewell MJ, Johnson A, Johnston S, Karelin A, Kaufman LJ, Koffas T, Kravitz S, Krücken R, Kuchenkov A, Kumar KS, Lan Y, Leonard DS, Li GS, Li S, Licciardi C, Lin YH, MacLellan R, Michel T, Mong B, Moore D, Murray K, Nelson R, Njoya O, Odian A, Ostrovskiy I, Piepke A, Pocar A, Retière F, Rowson PC, Russell JJ, Schmidt S, Schubert A, Sinclair D, Stekhanov V, Tarka M, Tolba T, Tsang R, Vogel P, Vuilleumier JL, Wagenpfeil M, Waite A, Walton T, Weber M, Wen LJ, Wichoski U, Wrede G, Yang L, Yen YR, Zeldovich OY, Zettlemoyer J, Ziegler T; EXO-200 Collaboration.

Phys Rev Lett. 2018 Feb 16;120(7):072701. doi: 10.1103/PhysRevLett.120.072701.

PMID:
29542972
39.

The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.

Andratschke N, Alheid H, Allgäuer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Gerum S, Guckenberger M, Hildebrandt G, Klement RJ, Lewitzki V, Ostheimer C, Papachristofilou A, Petersen C, Schneider T, Semrau R, Wachter S, Habermehl D.

BMC Cancer. 2018 Mar 13;18(1):283. doi: 10.1186/s12885-018-4191-2.

40.

Consensus recommendations for trabecular meshwork cell isolation, characterization and culture.

Keller KE, Bhattacharya SK, Borrás T, Brunner TM, Chansangpetch S, Clark AF, Dismuke WM, Du Y, Elliott MH, Ethier CR, Faralli JA, Freddo TF, Fuchshofer R, Giovingo M, Gong H, Gonzalez P, Huang A, Johnstone MA, Kaufman PL, Kelley MJ, Knepper PA, Kopczynski CC, Kuchtey JG, Kuchtey RW, Kuehn MH, Lieberman RL, Lin SC, Liton P, Liu Y, Lütjen-Drecoll E, Mao W, Masis-Solano M, McDonnell F, McDowell CM, Overby DR, Pattabiraman PP, Raghunathan VK, Rao PV, Rhee DJ, Chowdhury UR, Russell P, Samples JR, Schwartz D, Stubbs EB, Tamm ER, Tan JC, Toris CB, Torrejon KY, Vranka JA, Wirtz MK, Yorio T, Zhang J, Zode GS, Fautsch MP, Peters DM, Acott TS, Stamer WD.

Exp Eye Res. 2018 Jun;171:164-173. doi: 10.1016/j.exer.2018.03.001. Epub 2018 Mar 9. Review.

41.

Biological imaging for individualized therapy in radiation oncology: part II medical and clinical aspects.

Gkika E, Oehlke O, Bunea H, Wiedenmann N, Adebahr S, Nestle U, Zamboglou C, Kirste S, Fennell J, Brunner T, Gainey M, Baltas D, Langer M, Urbach H, Bock M, Meyer PT, Grosu AL.

Future Oncol. 2018 Apr;14(8):751-769. doi: 10.2217/fon-2017-0465. Epub 2018 Mar 9.

PMID:
29521519
42.

Dawning of the N=32 Shell Closure Seen through Precision Mass Measurements of Neutron-Rich Titanium Isotopes.

Leistenschneider E, Reiter MP, Ayet San Andrés S, Kootte B, Holt JD, Navrátil P, Babcock C, Barbieri C, Barquest BR, Bergmann J, Bollig J, Brunner T, Dunling E, Finlay A, Geissel H, Graham L, Greiner F, Hergert H, Hornung C, Jesch C, Klawitter R, Lan Y, Lascar D, Leach KG, Lippert W, McKay JE, Paul SF, Schwenk A, Short D, Simonis J, Somà V, Steinbrügge R, Stroberg SR, Thompson R, Wieser ME, Will C, Yavor M, Andreoiu C, Dickel T, Dillmann I, Gwinner G, Plaß WR, Scheidenberger C, Kwiatkowski AA, Dilling J.

Phys Rev Lett. 2018 Feb 9;120(6):062503. doi: 10.1103/PhysRevLett.120.062503.

PMID:
29481255
43.

Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection.

Kirste S, Kayser G, Zipfel A, Grosu AL, Brunner T.

Radiat Oncol. 2018 Feb 20;13(1):28. doi: 10.1186/s13014-018-0974-5.

44.

Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?

Gkika E, Vach W, Adebahr S, Schimek-Jasch T, Brenner A, Brunner TB, Kaier K, Prasse A, Müller-Quernheim J, Grosu AL, Zissel G, Nestle U.

PLoS One. 2018 Jan 25;13(1):e0192058. doi: 10.1371/journal.pone.0192058. eCollection 2018.

45.

The role of albumin-bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy.

Gkika E, Bettinger D, Krafft L, Schultheiss M, Neeff HP, Maruschke L, Schulenburg M, Adebahr S, Kirste S, Nestle U, Thimme R, Grosu AL, Brunner TB.

Strahlenther Onkol. 2018 May;194(5):403-413. doi: 10.1007/s00066-017-1256-0. Epub 2018 Jan 10.

PMID:
29322205
46.

Glycomimetic, Orally Bioavailable LecB Inhibitors Block Biofilm Formation of Pseudomonas aeruginosa.

Sommer R, Wagner S, Rox K, Varrot A, Hauck D, Wamhoff EC, Schreiber J, Ryckmans T, Brunner T, Rademacher C, Hartmann RW, Brönstrup M, Imberty A, Titz A.

J Am Chem Soc. 2018 Feb 21;140(7):2537-2545. doi: 10.1021/jacs.7b11133. Epub 2018 Jan 22.

PMID:
29272578
47.

Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.

Li J, Basler M, Alvarez G, Brunner T, Kirk CJ, Groettrup M.

Kidney Int. 2018 Mar;93(3):670-680. doi: 10.1016/j.kint.2017.09.023. Epub 2017 Dec 8.

PMID:
29229189
48.

Application of 19F NMR Spectroscopy for Content Determination of Fluorinated Pharmaceuticals.

Okaru AO, Brunner TS, Ackermann SM, Kuballa T, Walch SG, Kohl-Himmelseher M, Lachenmeier DW.

J Anal Methods Chem. 2017;2017:9206297. doi: 10.1155/2017/9206297. Epub 2017 Oct 18.

49.

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.

Gkika E, Hallauer L, Kirste S, Adebahr S, Bartl N, Neeff HP, Fritsch R, Brass V, Nestle U, Grosu AL, Brunner TB.

BMC Cancer. 2017 Nov 21;17(1):781. doi: 10.1186/s12885-017-3788-1.

50.

Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?

Gkika E, Vach W, Adebahr S, Schimek-Jasch T, Brenner A, Brunner TB, Kaier K, Prasse A, Müller-Quernheim J, Grosu AL, Zissel G, Nestle U.

PLoS One. 2017 Sep 28;12(9):e0185350. doi: 10.1371/journal.pone.0185350. eCollection 2017. Erratum in: PLoS One. 2018 Jan 25;13(1):e0192058.

Supplemental Content

Loading ...
Support Center